Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. QGEN
5. NDAQ
6. QS
7. BRO
8. BFH
9. SAP
10. AVEX

Go back to Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update

NovoCure Ltd. (NVCR) PT Raised to $59 at Wedbush

March 1, 2019 11:24 AM EST

Wedbush analyst David Nierengarten raised the price target on NovoCure Ltd. (NASDAQ: NVCR) to $59.00 (from $55.00) while maintaining a Outperform rating.

... More

Novocure (NVCR) Misses Q4 EPS by 4c, Revenues Miss

February 28, 2019 6:14 AM EST

Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $69.7 million versus the consensus estimate of $71.42 million.

Quarterly net revenues of $69.7 million, representing 30 percent growth versus the fourth quarter 2017 and 8 percent growth versus the third quarter 2018Full... More